New management can't get here quickly enough. T
Post# of 148147
The Delaware court's scathing comments about the stock issued to management should put an end, once and for all, to those who claim Pourhassan sold about $15 million in such stock for the benefit of the company.
Once competent management is in place, we can finally get leronlimab approved for HIV, and hopefully other indications, and be speared the constant drumbeat of false touts.